Phase 1b Trial of Dinaciclib With Pembrolizumab for Advanced Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Advanced or Metastatic Breast Cancer|Triple Negative Breast Cancer
Interventions: DRUG: Dinaciclib|DRUG: Pembrolizumab
Sponsor: Jo Chien
Collaborators: Merck Sharp & Dohme LLC